Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice

被引:25
|
作者
Gross, Volkmar [1 ]
Tank, Jens [1 ]
Partke, Hans-Joachim [3 ]
Plehm, Ralph [1 ]
Diedrich, Andre [4 ]
Goncalves, Andrey C. da Costa [1 ]
Luft, Friedrich C. [1 ,2 ]
Jordan, Jens [2 ]
机构
[1] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
[2] HELIOS Klin, Fac Med Charite, Franz Volhard Clin, Berlin, Germany
[3] Univ Dusseldorf, Deutsch Diabet Zentrum, Dusseldorf, Germany
[4] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol,Autonom Dysfunct Serv, Nashville, TN 37212 USA
来源
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL | 2008年 / 138卷 / 1-2期
关键词
NOD mice; blood pressure; diabetic neuropathy; autonomic nervous system; spectral analysis; baroreflex; SPONTANEOUS BAROREFLEX SENSITIVITY; HEART-RATE-VARIABILITY; BLOOD-PRESSURE; SPECTRAL-ANALYSIS; DIURNAL-VARIATION; NERVOUS CONTROL; NEUROPATHY; MELLITUS; RATS; DYSFUNCTION;
D O I
10.1016/j.autneu.2007.11.006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Non-Obese Diabetic (NOD) mice show profound pathomorphological changes in sympathetic ganglia during the development of type I diabetes mellitus. We tested the hypothesis that NOD mice represent an experimental model to investigate cardiovascular changes seen in humans with diabetic autonomic neuropathy. Blood glucose (BG) levels were measured once a week. Diabetes mellitus was diagnosed as BG levels exceeded 250 mg/dl twice. NOD mice that did not become diabetic served as control group. Blood pressure (BP) and heart rate (HR) were monitored by telemetry and baroreflex sensitivity (BRS) was calculated with the sequence method or with cross spectral analysis. The measurements were obtained before onset of diabetes and during the 4th week of diabetes. The onset of diabetes was accompanied by a continuous decline in HR (615 +/- 14 vs. 498 +/- 23 bpm), whereas BP values remained stable (108 +/- 2 vs. 111 +/- 2 mm Hg). The circadian HR rhythm increased in diabetic NOD mice. BRS was higher in diabetic NOD mice than in controls. Atropine reduced BRS more profoundly in diabetic mice compared to non-diabetic mice. Despite pathomorphological similarities of the diabetic autonomic neuropathy between patients with diabetes and diabetic NOD mice, the changes in blood pressure regulation are different. In conclusion the use of diabetic NOD mice as a functional model for human diabetes may be questioned. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:108 / 113
页数:6
相关论文
共 50 条
  • [31] Prevention of type 1 diabetes with dietary antioxidant cocktails in non-obese diabetic (NOD) mice
    Long, AC
    Ching, S
    Quan, N
    Boileau, T
    Bray, TM
    FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 : S34 - S34
  • [32] Immune dysregulation in B7-2-deficient non-obese diabetic (NOD) mice
    Jung, Cha-Gyun
    Cook, Shawna
    Jensen, Mark
    Kakazu, Rafael
    Soliven, Betty
    ANNALS OF NEUROLOGY, 2006, 60 : S67 - S67
  • [33] EVIDENCE FOR ABNORMAL THYMIC T-CELL DEVELOPMENT IN NON-OBESE DIABETIC (NOD) MICE
    ZIPRIS, D
    CROW, AR
    DELOVITCH, TL
    DIABETOLOGIA, 1989, 32 (07) : A560 - A560
  • [34] Identification of a novel transition period in non-obese diabetic (NOD) mice by cDNA microarray.
    Eckenrode, SE
    Ruan, QG
    Yang, P
    Shë, JX
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 566 - 566
  • [35] Characterization of methyl group metabolism in the non-obese diabetic (NOD) mouse
    Neuman, Joshua Charles
    Nieman, Kristin M.
    Schalinske, Kevin L.
    FASEB JOURNAL, 2010, 24
  • [36] Prevention of diabetes in the NOD (non-obese diabetic) mouse by LXR agonists
    Aboumrad, E.
    Husson, B.
    Madec, A. M.
    Theveniaux, J.
    Thivolet, C.
    DIABETES & METABOLISM, 2007, 33 : S113 - S114
  • [37] Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse
    Tahvili, Sahar
    Torngren, Marie
    Holmberg, Dan
    Leanderson, Tomas
    Ivars, Fredrik
    PLOS ONE, 2018, 13 (05):
  • [38] Islet-splenocyte cotransplantation in the non-obese diabetic (NOD) mouse
    Delatorre, AN
    Kuo, PC
    Bartlett, ST
    DIABETES, 1998, 47 : A341 - A341
  • [39] The non-obese diabetic (NOD) mouse: An animal model for autoimmune thyroiditis
    Many, MC
    Maniratunga, S
    Denef, JF
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 : 17 - 20
  • [40] Syntaxin 4 Enrichment in β-Cells Prevents Conversion to Autoimmune Diabetes in Non-Obese Diabetic (NOD) Mice
    Oh, Eunjin
    McCown, Erika M.
    Ahn, Miwon
    Garcia, Pablo A.
    Branciamore, Sergio
    Tang, Shanshan
    Zeng, De-Fu
    Roep, Bart O.
    Thurmond, Debbie C.
    DIABETES, 2021, 70 (12) : 2837 - 2849